Table 1.
Endpoint of the economic evaluation | Derived from/questionnaire name | Time of measurement (Month) | |||||
---|---|---|---|---|---|---|---|
Baseline | M 3 | M 6 | M 9 | M 12 | M 15 | ||
Incidence rate of depression | Depression module of the SCID | X | X | X | |||
Severity of depression | QIDS/Hamilton Scale | X | X | X | X | ||
QALYs | SF-36 EQ-5D |
X | X | X | X | X | X |
MCI (three-step screening) | Interview of Strawbridge MMSE CDR SKT + MWTB |
X | X* | ||||
Health sector and patients' costs | Cost questionnaire | X | X | X | X | ||
Laboratory parameters | Safety parameters: ALT, AST, creatinine, TSH | X | |||||
HbA1c | X | X | X | X | X | X | |
Diabetes-related emotional distress, coping, diabetes self-care activities | PAID SDSCA FKV-15 |
X | X | X | X | ||
Interpersonal aspects | SE H-Skala K-INK |
X | X | X | X |
*those patients with a positive MCI screening at baseline